- Home
- AAP vs TARS Comparison
AAP vs TARS Comparison
Compare AAP & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAP
- TARS
- Stock Information
- Founded
- AAP 1929
- TARS 2016
- Country
- AAP United States
- TARS United States
- Employees
- AAP N/A
- TARS N/A
- Industry
- AAP Auto & Home Supply Stores
- TARS Medicinal Chemicals and Botanical Products
- Sector
- AAP Consumer Discretionary
- TARS Health Care
- Exchange
- AAP Nasdaq
- TARS Nasdaq
- Market Cap
- AAP 3.3B
- TARS 2.8B
- IPO Year
- AAP N/A
- TARS 2020
- Fundamental
- Price
- AAP $50.56
- TARS $73.26
- Analyst Decision
- AAP Hold
- TARS Strong Buy
- Analyst Count
- AAP 20
- TARS 7
- Target Price
- AAP $52.28
- TARS $69.86
- AVG Volume (30 Days)
- AAP 1.9M
- TARS 499.8K
- Earning Date
- AAP 10-30-2025
- TARS 11-04-2025
- Dividend Yield
- AAP 1.99%
- TARS N/A
- EPS Growth
- AAP N/A
- TARS N/A
- EPS
- AAP N/A
- TARS N/A
- Revenue
- AAP $8,624,327,000.00
- TARS $366,100,000.00
- Revenue This Year
- AAP N/A
- TARS $139.46
- Revenue Next Year
- AAP $0.89
- TARS $49.91
- P/E Ratio
- AAP N/A
- TARS N/A
- Revenue Growth
- AAP N/A
- TARS 182.44
- 52 Week Low
- AAP $28.89
- TARS $38.51
- 52 Week High
- AAP $70.00
- TARS $76.81
- Technical
- Relative Strength Index (RSI)
- AAP 44.78
- TARS 60.27
- Support Level
- AAP $46.11
- TARS $65.93
- Resistance Level
- AAP $52.17
- TARS $76.38
- Average True Range (ATR)
- AAP 3.16
- TARS 3.00
- MACD
- AAP 0.19
- TARS 0.15
- Stochastic Oscillator
- AAP 31.19
- TARS 70.32
About AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.